Journal of Pediatric Neurology 2012; 10(04): 235-245
DOI: 10.3233/JPN-120578
Review Article
Georg Thieme Verlag KG Stuttgart – New York

Treatment of mitochondrial disorders

Monika Sharma
a   Department of Pediatrics, Christian Medical College, Ludhiana, Punjab, India
,
Sheffali Gulati
b   Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
,
Anita Choudhary
c   Department of Pediatrics, Advanced Pediatric Centre, Chandigarh, India
› Author Affiliations

Subject Editor:
Further Information

Publication History

23 February 2012

30 May 2012

Publication Date:
30 July 2015 (online)

Abstract

Mitochondria are important intracellular organelles that are widely distributed and have a central role in metabolic activity. Production of adenosine triphosphate by oxidative phosphorylation, is the principal function of mitochondria. Defects of mitochondrial metabolism cause a wide range of human diseases. They may present as single or multisystem disease at any age. Treatment of mitochondrial disorders is a challenge, as there is only symptomatic therapy available. As few randomized and controlled studies are published, much of the experience of the treatment of mitochondrial disease is based upon anecdotal reports and small case series, which demonstrate effect of some of the measures available. In this paper, we review the various treatments studied and practiced in the context of mitochondrial disorders. We will also outline the evidence in favor or against them.